Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up

BACKGROUND: Gliptins should have beneficial effects beyond glycemic control, potentially on the pathophysiology of cardiovascular (CV) diseases, with some basic studies demonstrating this possibility. However, we are yet to answer whether there are any direct CV effects in the clinical setting. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Takashi, Iwanaga, Yoshitaka, Miyaji, Yuki, Nohara, Ryuji, Ishimura, Takao, Miyazaki, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818390/
https://www.ncbi.nlm.nih.gov/pubmed/27036865
http://dx.doi.org/10.1186/s12933-016-0371-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818390/
https://www.ncbi.nlm.nih.gov/pubmed/27036865
http://dx.doi.org/10.1186/s12933-016-0371-z

Ejemplares similares